Answers are grounded in this paper and cite their sources.
Standardization of therapy with oral anticoagulants can be achieved by measuring the performance of various thromboplastins against standard reference plasmas. The reference plasmas are assayed with regard to those coagulation factors (II, VII, and X) affected by oral anticoagulants and measured by the one-stage prothrombin time. Given these common points of reference, and in the absence of an acceptable mathematic comparison among various thromboplastins, a suggestion is made for the therapeutic range to be achieved for each of the thromboplastins studied. The suggested ranges are equivalent to each other and to a range of 10 to 20% reduction in the coagulation factors affected by oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Miale et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: